Patents-Review.com
🔗 Permalink
Assignee profile:

Pharmexa Inc.

City:

San Diego, California

Country:

United States

Published Applications:

12

Last publication date:

2011-04-28

Patent Grants:

7

Last grant date:

2015-03-03

Top Inventors for applications by Pharmexa Inc.

These are the the leading inventors for applications assigned to Pharmexa Inc.:

Recent patent applications by Pharmexa Inc.

Pharmexa Inc. based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2011-04-28
US20110097352A9
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

 #2 | 2010-10-28 ✅ Patent 8,969,542 granted on 2015-03-03
US20100272750A1
Chemistry; metallurgy

HPV polyepitope constructs and uses thereof

 #3 | 2010-04-22
US20100099613A1
Chemistry; metallurgy

PEPTIDES FOR INDUCING A CTL AND/OR HTL RESPONSE TO HEPATITIS C VIRUS

 #4 | 2010-03-18
US20100068228A1
Chemistry; metallurgy

Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions

 #5 | 2009-12-17
US20090311283A1
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

 #6 | 2008-12-09 ✅ Patent 7,462,354 granted on 2008-12-09
US9894018
-

Method and system for optimizing minigenes and peptides encoded thereby

 #7 | 2008-04-29 ✅ Patent 7,364,741 granted on 2008-04-29
US8170344
-

Peptides of human Papilloma virus for use in human T cell response inducing compositions

 #8 | 2008-02-07 ✅ Patent 9,511,134 granted on 2016-12-06
US20080032921A1
Human necessities

Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions

 #9 | 2007-04-10 ✅ Patent 7,202,351 granted on 2007-04-10
US9709774
-

Alteration of immune response using pan DR-binding peptides

 #10 | 2007-03-15
US20070059799A1
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

 #11 | 2007-03-08 ✅ Patent 7,572,882 granted on 2009-08-11
US20070053922A1
Chemistry; metallurgy

Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions

 #12 | 2005-03-24 ✅ Patent 7,611,713 granted on 2009-11-03
US20050063983A1
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide compositions
AssigneeID:

213841 ⎘